Yuri Gleba, Ph.D.
- CEO -

Dr. Gleba has over 30 years of research and management experience in plant genetics and biotechnology. (M. Sc., Kiev University, 1971; Ph.D., Institute of Botany, Academy of Sciences of Ukraine, 1974; D.Sc., Leningrad University, 1980).

Dr. Gleba’s pioneering research in plant genetics, physiology and biotechnology was published in more than 200 research papers, books and over 30 patent families, and has earned the respect of the international scientific community as is evidenced by his election to the World Academy of Arts and Science (Rome), the European Academy (Academia Europaea, London), the National German Academy Leopoldina (Halle), the National Ukrainian Academy of Sciences (Kiev), the Lithuanian Academy of Science (Vilnius) and the Bavarian Academy of Sciences (Munich). He received a Doctor Honoris Causa title from his alma mater, Kiev State University. In recognition of his outstanding scientific contributions, he also received numerous international and national awards and prizes, including Koerber Prize (Hamburg), A. von Humboldt Prize (Bonn), USSR State Prize (Moscow), State Prize of Ukraine (Kiev), etc.

He founded the Institute of Cell Biology and Genetic Engineering, Ukrainian Academy of Sciences, Kiev, Ukraine, in 1989, and was serving as its Director until 2010; currently, he is a Honorary Director of the Institute.

Dr. Gleba left former USSR in 1991 and joined American Cyanamid Company, Princeton, NJ, where he developed research efforts in plant biotechnology and genomics and crop engineering, first as a group leader/manager, and, since 1997, as a Director of Crop Engineering Department. Dr. Gleba left American Cyanamid/American Home Products in 1999 and founded Icon Genetics, Princeton/Munich/Halle, a plant biotechnology company group; he has been serving since its inception as its CEO. Under his leadership, Icon has developed multiple plant expression technologies, including the magnICON® transient technology that has been recently brought to a commercial level and cGMP compliance and is being used to support clinical trials of the product candidates developed by Icon/Bayer. Icon has created one of the best IP portfolios in plant biotechnology that currently includes over 320 issued patents representing 42 patent families of patents/applications. He also co-founded two other companies, Phytomedics Inc., USA, and Nomad Bioscience GmbH, Germany. In January 2012, Dr. Gleba engineered the acquisition of Icon Genetics from Bayer by Nomad Bioscience.

During his entire carrier, Dr. Gleba was involved in university education. He was a supervisor of 35 Ph D students and was lecturing or holding adjunct positions for many years at the universities of USSR, USA, Belgium, Ukraine and Germany.

Dr. Gleba actively managed or supervised many international foundations: UNESCO Plant Biotechnology Program (Paris), International Soros Foundation (New York-Moscow), International Soros Science Education Program (Washington-Moscow), Renaissance Foundation (Kyiv), INTAS (Brussels), EPSO (Brussels), etc.

send email to Yuri Gleba

Yuri Gleba, Ph.D.
- CEO -

Dr. Gleba has over 30 years of research and management experience in plant genetics and biotechnology. (M. Sc., Kiev University, 1971; Ph.D., Institute of Botany, Academy of Sciences of Ukraine, 1974; D.Sc., Leningrad University, 1980).

Dr. Gleba’s pioneering research in plant genetics, physiology and biotechnology was published in more than 200 research papers, books and over 30 patent families, and has earned the respect of the international scientific community as is evidenced by his election to the World Academy of Arts and Science (Rome), the European Academy (Academia Europaea, London), the National German Academy Leopoldina (Halle), the National Ukrainian Academy of Sciences (Kiev), the Lithuanian Academy of Science (Vilnius) and the Bavarian Academy of Sciences (Munich). He received a Doctor Honoris Causa title from his alma mater, Kiev State University. In recognition of his outstanding scientific contributions, he also received numerous international and national awards and prizes, including Koerber Prize (Hamburg), A. von Humboldt Prize (Bonn), USSR State Prize (Moscow), State Prize of Ukraine (Kiev), etc.

He founded the Institute of Cell Biology and Genetic Engineering, Ukrainian Academy of Sciences, Kiev, Ukraine, in 1989, and was serving as its Director until 2010; currently, he is a Honorary Director of the Institute.

Dr. Gleba left former USSR in 1991 and joined American Cyanamid Company, Princeton, NJ, where he developed research efforts in plant biotechnology and genomics and crop engineering, first as a group leader/manager, and, since 1997, as a Director of Crop Engineering Department. Dr. Gleba left American Cyanamid/American Home Products in 1999 and founded Icon Genetics, Princeton/Munich/Halle, a plant biotechnology company group; he has been serving since its inception as its CEO. Under his leadership, Icon has developed multiple plant expression technologies, including the magnICON® transient technology that has been recently brought to a commercial level and cGMP compliance and is being used to support clinical trials of the product candidates developed by Icon/Bayer. Icon has created one of the best IP portfolios in plant biotechnology that currently includes over 320 issued patents representing 42 patent families of patents/applications. He also co-founded two other companies, Phytomedics Inc., USA, and Nomad Bioscience GmbH, Germany. In January 2012, Dr. Gleba engineered the acquisition of Icon Genetics from Bayer by Nomad Bioscience.

During his entire carrier, Dr. Gleba was involved in university education. He was a supervisor of 35 Ph D students and was lecturing or holding adjunct positions for many years at the universities of USSR, USA, Belgium, Ukraine and Germany.

Dr. Gleba actively managed or supervised many international foundations: UNESCO Plant Biotechnology Program (Paris), International Soros Foundation (New York-Moscow), International Soros Science Education Program (Washington-Moscow), Renaissance Foundation (Kyiv), INTAS (Brussels), EPSO (Brussels), etc.

send email to Yuri Gleba